A serum microRNA signature for enhanced selection of people for lung cancer screening.
作者信息
Yu Haixin, Raut Janhavi R, Bhardwaj Megha, Zhang Yan, Sandner Evelin, Schöttker Ben, Holleczek Bernd, Schrotz-King Petra, Brenner Hermann
机构信息
Division of Clinical Epidemiology and Aging Research, German Cancer Research Center (DKFZ), Heidelberg, 69120, Baden-Württemberg, Germany.
Medical Faculty Heidelberg, University of Heidelberg, Heidelberg, 69120, Baden-Württemberg, Germany.
出版信息
Cancer Commun (Lond). 2022 Nov;42(11):1222-1225. doi: 10.1002/cac2.12346. Epub 2022 Aug 4.
Abstract
摘要
相似文献
1
A serum microRNA signature for enhanced selection of people for lung cancer screening.一种用于增强肺癌筛查人群选择的血清微小RNA特征。
Cancer Commun (Lond). 2022 Nov;42(11):1222-1225. doi: 10.1002/cac2.12346. Epub 2022 Aug 4.
2
microRNA and Lung Cancer.微小RNA与肺癌
Adv Exp Med Biol. 2015;889:153-77. doi: 10.1007/978-3-319-23730-5_9.
3
MicroRNA Assays for Diagnosis Lung Cancer Biopsy.用于肺癌活检诊断的微小RNA检测
J Thorac Oncol. 2015 Jun;10(6):e52-3. doi: 10.1097/JTO.0000000000000528.
4
MicroRNA-based biomarkers for diagnosis of non-small cell lung cancer (NSCLC).基于 microRNA 的生物标志物用于诊断非小细胞肺癌（NSCLC）。
Thorac Cancer. 2020 Mar;11(3):762-768. doi: 10.1111/1759-7714.13337. Epub 2020 Jan 28.
5
Reply to "MiR-205 and miR-375 microRNA Assays to Distinguish Squamous Cell Carcinoma From Adenocarcinoma in Lung Cancer Biopsies".对《MiR-205和miR-375微小RNA检测用于区分肺癌活检中的鳞状细胞癌和腺癌》的回复
J Thorac Oncol. 2015 Jun;10(6):e53. doi: 10.1097/JTO.0000000000000539.
6
A Novel Serum 4-microRNA Signature for Lung Cancer Detection.一种用于肺癌检测的新型血清4-微小RNA标志物
Sci Rep. 2015 Jul 23;5:12464. doi: 10.1038/srep12464.
7
miR-1254 and miR-574-5p: serum-based microRNA biomarkers for early-stage non-small cell lung cancer.miR-1254 和 miR-574-5p：基于血清的早期非小细胞肺癌 microRNA 生物标志物。
J Thorac Oncol. 2011 Mar;6(3):482-8. doi: 10.1097/JTO.0b013e318208c785.
8
Identification of ten serum microRNAs from a genome-wide serum microRNA expression profile as novel noninvasive biomarkers for nonsmall cell lung cancer diagnosis.从全基因组血清 microRNA 表达谱中鉴定出的十个血清 microRNAs 作为非小细胞肺癌诊断的新型无创生物标志物。
Int J Cancer. 2012 Apr 1;130(7):1620-8. doi: 10.1002/ijc.26177. Epub 2011 Aug 3.
9
Clinical implication of microrna for lung cancer.微小RNA对肺癌的临床意义
Cancer Biother Radiopharm. 2013 May;28(4):261-7. doi: 10.1089/cbr.2012.1401. Epub 2013 Mar 15.
10
MicroRNA dysregulational synergistic network: discovering microRNA dysregulatory modules across subtypes in non-small cell lung cancers.miRNA 失调协同网络：在非小细胞肺癌的不同亚型中发现 miRNA 失调调控模块。
BMC Bioinformatics. 2018 Dec 21;19(Suppl 20):504. doi: 10.1186/s12859-018-2536-0.
引用本文的文献
1
Promising microRNAs in pre-diagnostic serum associated with lung cancer up to eight years before diagnosis: a HUNT study.与肺癌诊断前 8 年相关的预诊断血清中具有前景的 microRNAs：一项 HUNT 研究。
J Cancer Res Clin Oncol. 2024 Jul 20;150(7):355. doi: 10.1007/s00432-024-05882-4.
2
Cancer-specific risk prediction with a serum microRNA signature.基于血清 microRNA 特征的癌症特异性风险预测。
Cancer Sci. 2024 Jun;115(6):2049-2058. doi: 10.1111/cas.16135. Epub 2024 Mar 24.
本文引用的文献
1
Screening for Lung Cancer: US Preventive Services Task Force Recommendation Statement.肺癌筛查：美国预防服务工作组推荐声明。
JAMA. 2021 Mar 9;325(10):962-970. doi: 10.1001/jama.2021.1117.
2
Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries.《全球癌症统计数据 2020：全球 185 个国家和地区 36 种癌症的发病率和死亡率估计》。
CA Cancer J Clin. 2021 May;71(3):209-249. doi: 10.3322/caac.21660. Epub 2021 Feb 4.
3
Reduced Lung-Cancer Mortality with Volume CT Screening in a Randomized Trial.随机试验中 CT 容积筛查降低肺癌死亡率
N Engl J Med. 2020 Feb 6;382(6):503-513. doi: 10.1056/NEJMoa1911793. Epub 2020 Jan 29.
4
Lung cancer screening with low-dose CT: a world-wide view.低剂量CT肺癌筛查：全球视角
Transl Lung Cancer Res. 2018 Jun;7(3):234-242. doi: 10.21037/tlcr.2018.05.12.
5
Implications of Nine Risk Prediction Models for Selecting Ever-Smokers for Computed Tomography Lung Cancer Screening.九种风险预测模型对选择持续吸烟者进行计算机断层扫描肺癌筛查的影响。
Ann Intern Med. 2018 Jul 3;169(1):10-19. doi: 10.7326/M17-2701. Epub 2018 May 15.
6
Serum and blood based biomarkers for lung cancer screening: a systematic review.血清和血液生物标志物在肺癌筛查中的应用：系统评价。
BMC Cancer. 2018 Feb 13;18(1):181. doi: 10.1186/s12885-018-4024-3.
7
Smoking and Lung Cancer: A Geo-Regional Perspective.吸烟与肺癌：地域视角
Front Oncol. 2017 Sep 1;7:194. doi: 10.3389/fonc.2017.00194. eCollection 2017.
8
Risk prediction models for selection of lung cancer screening candidates: A retrospective validation study.用于选择肺癌筛查候选者的风险预测模型：一项回顾性验证研究。
PLoS Med. 2017 Apr 4;14(4):e1002277. doi: 10.1371/journal.pmed.1002277. eCollection 2017 Apr.
9
Selecting High-Risk Individuals for Lung Cancer Screening: A Prospective Evaluation of Existing Risk Models and Eligibility Criteria in the German EPIC Cohort.为肺癌筛查选择高危个体：对德国EPIC队列中现有风险模型和资格标准的前瞻性评估
Cancer Prev Res (Phila). 2015 Sep;8(9):777-85. doi: 10.1158/1940-6207.CAPR-14-0424. Epub 2015 Jun 15.
10
Reduced lung-cancer mortality with low-dose computed tomographic screening.低剂量计算机断层扫描筛查可降低肺癌死亡率。
N Engl J Med. 2011 Aug 4;365(5):395-409. doi: 10.1056/NEJMoa1102873. Epub 2011 Jun 29.
Zotero 插件